You are on page 1of 1

Federal Register / Vol. 72, No.

14 / Tuesday, January 23, 2007 / Notices 2907

DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Elimination Act (PREA) Update; Agency


reports; Quarterly Report by Office of
Drug Enforcement Administration Drug Enforcement Administration Justice Programs.
Contact Person for More Information:
Manufacturer of Controlled Manufacturer of Controlled Larry Solomon, Deputy Director, 202–
Substances; Notice of Application Substances; Notice of Application 307–3106, ext. 44254.
Pursuant to § 1301.33(a) of Title 21 of Morris L. Thigpen,
Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR),
the Code of Federal Regulations (CFR), Director.
this is notice that on September 20,
this is notice that on August 21, 2006, [FR Doc. 07–255 Filed 1–22–07; 8:45 am]
2006, Organix Inc., 240 Salem Street,
Cedarburg Pharmaceuticals, Inc., 870 Woburn, Massachusetts 01801, made BILLING CODE 4410–30–M
Badger Circle, Grafton, Wisconsin application by letter to the Drug
53024, made application by renewal to Enforcement Administration (DEA) to
the Drug Enforcement Administration be registered as a bulk manufacturer of NUCLEAR REGULATORY
(DEA) to be registered as a bulk Tetrahydrocannabinols (7370), a basic COMMISSION
manufacturer of the basic classes of class of controlled substance listed in
controlled substances listed in schedule schedule II. Agency Information Collection
The company plans on manufacturing Activities: Proposed Collection:
I and II:
this controlled substance for sale to its Comment Request
Drug Schedule customers. These customers will sell the AGENCY: U.S. Nuclear Regulatory
drug in small quantities for research Commission (NRC).
Tetrahydrocannabinols (7370) ..... I purposes or as drug standards for ACTION: Notice of pending NRC action to
Dihydromorphine (9145) ............... I forensic laboratories.
Dihydrocodeine (9120) ................. II submit an information collection
Any other such applicant and any
Oxycodone (9143) ........................ II request to OMB and solicitation of
person who is presently registered with
Hydromorphone (9150) ................ II public comment.
DEA to manufacture such a substance
Hydrocodone (9193) ..................... II may file comments or objections to the SUMMARY: The NRC is preparing a
Sufentanil (9740) .......................... II issuance of the proposed registration submittal to OMB for review of
Fentanyl (9801) ............................ II pursuant to 21 CFR 1301.33(a). continued approval of information
Remifentanil (9739) ...................... II Any such written comments or collections under the provisions of the
objections being sent via regular mail Paperwork Reduction Act of 1995 (44
The company plans to manufacture should be addressed, in quintuplicate, U.S.C. Chapter 35).
the listed controlled substances in bulk to the Deputy Assistant Administrator,
for distribution to its customers. Office of Diversion Control, Drug Information Pertaining to the
Enforcement Administration, Requirement To Be Submitted
Any other such applicant and any
Washington, DC 20537, Attention: DEA 1. The title of the information
person who is presently registered with Federal Register Representative/ODL; or
DEA to manufacture such substances collection: NRC Form 314, Certificate of
any being sent via express mail should Disposition of Materials.
may file comments or objections to the be sent to DEA Headquarters, Attention: 2. Current OMB approval numbers:
issuance of the proposed registration DEA Federal Register Representative/ 3150–0028.
pursuant to 21 CFR 1301.33(a). ODL, 2401 Jefferson-Davis Highway, 3. How often the collection is
Any such written comments or Alexandria, Virginia 22301; and must be required: The form is submitted once,
objections being sent via regular mail filed no later than March 26, 2007. when a licensee terminates its license.
should be addressed, in quintuplicate, Dated: January 16, 2007. 4. Who is required or asked to report:
to the Deputy Assistant Administrator, Joseph T. Rannazzisi, Persons holding an NRC license for the
Office of Diversion Control, Drug Deputy Assistant Administrator, Office of possession and use of radioactive
Enforcement Administration, Diversion Control, Drug Enforcement byproduct, source, or special nuclear
Washington, DC 20537, Attention: DEA Administration. material who are ceasing licensed
Federal Register Representative/ODL; or [FR Doc. E7–851 Filed 1–22–07; 8:45 am] activities and terminating the license.
any being sent via express mail should BILLING CODE 4410–09–P 5. The estimated number of annual
be sent to DEA Headquarters, Attention: respondents: 171.
DEA Federal Register Representative/ 6. The number of hours needed
ODL, 2401 Jefferson-Davis Highway, DEPARTMENT OF JUSTICE annually to complete the requirement or
Alexandria, Virginia 22301; and must be request: 85.5.
National Institute of Corrections 7. Abstract: NRC Form 314 furnishes
filed no later than March 26, 2007.
information to NRC regarding transfer or
Dated: January 16, 2007. Advisory Board Meeting other disposition of radioactive material
Joseph T. Rannazzisi, Time and Date: 8 a.m. to 4:30 p.m. on by licensees who wish to terminate their
Deputy Assistant Administrator, Office of Monday, February 26, 2007. 8 a.m. to licenses. The information is used by
Diversion Control, Drug Enforcement 4:30 p.m. on Tuesday, February 27, NRC as part of the basis for its
Administration. 2007. determination that the facility has been
[FR Doc. E7–850 Filed 1–22–07; 8:45 am] Place: American Correctional cleared of radioactive material before
mstockstill on PROD1PC70 with NOTICES

BILLING CODE 4410–09–P Association, 206 North Washington the facility is released for unrestricted
Street, Suite 200, Alexandria, Virginia use.
22314, 1 (800) 222–5646. Submit, by March 26, 2007, comments
Status: Open. that address the following questions:
Matters to be Considered: Reports; 1. Is the proposed collection of
Faith Based; Mental health; Prison Rape information necessary for the NRC to

VerDate Aug<31>2005 19:33 Jan 22, 2007 Jkt 211001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\23JAN1.SGM 23JAN1

You might also like